Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Song Zhang, Zhujun Cheng, Yanan Wang & Tianyu Han. (2021) The Risks of miRNA Therapeutics: In a Drug Target Perspective. Drug Design, Development and Therapy 15, pages 721-733.
Read now
Read now
Xin Gao, Wenwen Zheng, Lili Ye, Xiaohong Wen, Shunlan Wang, Hui Cao, Xi Liu, Denggao Huang, Fei Wang & Shufang Zhang. (2019) Exploration of bladder cancer-associated methylated miRNAs by methylated DNA immunoprecipitation sequencing. OncoTargets and Therapy 12, pages 6165-6174.
Read now
Read now
Busheng Xue, Jiansong Zhao, Penghui Feng, Jia Xing, Hongliang Wu & Yan Li. (2019) Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies. OncoTargets and Therapy 12, pages 549-559.
Read now
Read now
Qinglei Kong, Jianhua Han, Hong Deng, Feilong Wu, Shaozhong Guo & Zhiqiang Ye. (2018) miR-431-5p alters the epithelial-to-mesenchymal transition markers by targeting UROC28 in hepatoma cells. OncoTargets and Therapy 11, pages 6489-6503.
Read now
Read now
Articles from other publishers (17)
Justyna Raczkowska, Agnieszka Bielska, Adam Krętowski & Magdalena Niemira. (2023) Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients. Frontiers in Oncology 13.
Crossref
Crossref
Hang Li, Shuya Zhao, Xin Chen, Guoxing Feng, Zhiyuan Chen & Saijun Fan. (2022) MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3. Carcinogenesis 43:3, pages 288-296.
Crossref
Crossref
Luděk Záveský, Eva Jandáková, Vít Weinberger, Veronika Hanzíková, Ondřej Slanař & Milada Kohoutová. (2022) Ascites in ovarian cancer: MicroRNA deregulations and their potential roles in ovarian carcinogenesis. Cancer Biomarkers 33:1, pages 1-16.
Crossref
Crossref
Sarayut Geater, Pichitpon Chaniad, Keson Trakunran, Warangkana Keeratichananont, Suhaimee Buya, Paramee Thongsuksai & Pritsana Raungrut. (2021) Diagnostic and prognostic value of serum miR‑145 and vascular endothelial growth factor in non‑small cell lung cancer. Oncology Letters 23:1.
Crossref
Crossref
Liangliang Xu, Yanfang Zhang, Jianwei Tang, Peng Wang, Lian Li, Xiaokai Yan, Xiaobo Zheng, Shengsheng Ren, Ming Zhang & Mingqing Xu. (2019) The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies. Cancer Epidemiology, Biomarkers & Prevention 28:5, pages 867-881.
Crossref
Crossref
Qun Liu, Jianhui Chen, Baolan Wang, Yulong Zheng, Yufeng Wan, Yi Wang, Liyang Zhou, Shu Liu, Gang Li & Yi Yan. (2018)
Retracted
: miR‐145 modulates epithelial‐mesenchymal transition and invasion by targeting ZEB2 in non–small cell lung cancer cell lines
. Journal of Cellular Biochemistry 120:5, pages 8409-8418.
Crossref
Crossref
Yong Cui, Guanlong Li, Xin Zhang, Fangfang Dai & Rongxiang Zhang. (2018) Increased MALAT1 expression contributes to cisplatin resistance in non‑small cell lung cancer. Oncology Letters.
Crossref
Crossref
Alice Ramassone, Sara Pagotto, Angelo Veronese & Rosa Visone. (2018) Epigenetics and MicroRNAs in Cancer. International Journal of Molecular Sciences 19:2, pages 459.
Crossref
Crossref
Gui‐Min Chen, A‐Juan Zheng, Jing Cai, Ping Han, Hong‐Bo Ji & Le‐Le Wang. (2017)
Retracted:
microRNA‐145‐3p inhibits non‐small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway
. Journal of Cellular Biochemistry 119:1, pages 885-895.
Crossref
Crossref
Yongmei Chang, Wensen Yan, Cong Sun, Qingfeng Liu, Jun Wang & Mingzhi Wang. (2017) miR‑145‑5p inhibits epithelial‑mesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in non‑small cell lung cancer cells. Oncology Letters.
Crossref
Crossref
Chiara De Santi, Ombretta Melaiu, Alessandra Bonotti, Luciano Cascione, Gianpiero Di Leva, Rudy Foddis, Alfonso Cristaudo, Marco Lucchi, Marco Mora, Anna Truini, Andrea Tironi, Bruno Murer, Renzo Boldorini, Monica Cipollini, Federica Gemignani, Pierluigi Gasparini, Luciano Mutti & Stefano Landi. (2017) Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism. Scientific Reports 7:1.
Crossref
Crossref
Menglin Xu, Diane C. Wang, Xiangdong Wang & Yong Zhang. (2017) Correlation between mucin biology and tumor heterogeneity in lung cancer. Seminars in Cell & Developmental Biology 64, pages 73-78.
Crossref
Crossref
Ting-qing Gan, Zu-cheng Xie, Rui-xue Tang, Tong-tong Zhang, Dong-yao Li, Zu-yun Li & Gang Chen. (2017) Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data. Tumor Biology 39:3, pages 101042831769168.
Crossref
Crossref
Jichao Liu, Yongshuang Li, Ying Zou, Jiakui Zhang, Jiaxiang An, Jiao Guo, Minghui Ma & Dongqiu Dai. (2017) MicroRNA-497 acts as a tumor suppressor in gastric cancer and is downregulated by DNA methylation. Oncology Reports 38:1, pages 497-505.
Crossref
Crossref
Zuzana Pastorkova, Jozef Skarda & Jozef Andel. (2016) The role of microRNA in metastatic processes of non-small cell lung carcinoma. Biomedical Papers 160:3, pages 343-357.
Crossref
Crossref
Jingjing Du, Xiao Cheng, Linyuan Shen, Zhendong Tan, Jia Luo, Xiaoqian Wu, Chendong Liu, Qiong Yang, Yanzhi Jiang, Guoqing Tang, Xuewei Li, Shunhua Zhang & Li Zhu. (2016) Methylation of miR-145a-5p promoter mediates adipocytes differentiation. Biochemical and Biophysical Research Communications 475:1, pages 140-148.
Crossref
Crossref
Yingying Zhang, Xucheng Yang, Haijun Wu, Weibin Zhou & Zhenzhen Liu. (2015) MicroRNA-145 inhibits migration and invasion via inhibition of fascin�1 protein expression in non-small-cell lung cancer cells. Molecular Medicine Reports.
Crossref
Crossref